Division of Cardiothoracic Surgery, Department of Surgery.
Division of Experimental Surgery, La Paz University Hospital Madrid, Spain.
Transplantation. 2018 Sep;102(9):1459-1466. doi: 10.1097/TP.0000000000002250.
Chronic rejection is the Achilles heel of modern lung transplantation, characterized by a slow, progressive decline in allograft function. Clinically, this manifests as obstructive disease, restrictive disease, or a mixture of the 2 depending on the underlying pathology. The 2 major phenotypes of chronic rejection include bronchiolitis obliterans syndrome and restrictive allograft syndrome. The last decade of research has revealed that each of these phenotypes has a unique underlying pathophysiology which may require a distinct treatment regimen for optimal control. Insights into the intricate alloimmune pathways contributing to chronic rejection have been gained from both large and small animal models, suggesting directions for future research. In this review, we explore the pathological hallmarks of chronic rejection, recent insights gained from both clinical and basic science research, and the current state of animal models of chronic lung rejection.
慢性排斥反应是现代肺移植的阿喀琉斯之踵,其特征是移植物功能逐渐缓慢下降。临床上,这表现为阻塞性疾病、限制性疾病,或根据基础病理学的不同混合表现。慢性排斥反应的 2 种主要表型包括闭塞性细支气管炎综合征和限制性移植物综合征。过去十年的研究表明,这些表型中的每一种都有独特的潜在病理生理学,这可能需要独特的治疗方案来实现最佳控制。从小型和大型动物模型中获得的关于导致慢性排斥反应的复杂同种免疫途径的见解,为未来的研究提供了方向。在这篇综述中,我们探讨了慢性排斥反应的病理特征、最近从临床和基础科学研究中获得的见解,以及慢性肺排斥反应的动物模型的现状。